BHAVANI SOMAVARAM: Open Payments
NPI 1487230645 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 11 payments from 9 companies in 2025. Trend: 2023 $80 · 2024 $305 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| OPKO Pharmaceuticals, LLC | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| AKEBIA THERAPEUTICS INC | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Ardelyx, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Kerendia, RAYALDEE, Fabhalta, Vafseo, FUROSCIX, CRYSVITA, IBSRELA, FARXIGA.
Industry payments across FL — which companies pay providers there.
